Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Svédország
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleCAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
- Where
- Huddinge, Uppsala
- Életkor
- 18 év and over
- People
- 18
- Run by
- Uppsala University
See details and how to joinNCT06002659 · EU 2024-511844-18-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Gothenburg
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 2. fázisNot yet taking people in SvédországHOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before
- Where
- DO NOT EDIT
- Életkor
- 65 év and over
- People
- 276 worldwide
- Run by
- Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
See details and how to join2025-524230-25-00 · EU 2025-524230-25-00 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Gothenburg, Stockholm
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 2. fázisTaking peopleEfficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
- Where
- Uppsala
- Életkor
- 18 év to 70 év
- People
- 213 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866 · EU 2023-506270-13-00 - 2. fázisTaking peopleVaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
- Where
- Gothenburg, Linköping, Lund, Stockholm, Uppsala
- Életkor
- 18 év to 45 év
- People
- 100
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06793410 - 3. fázisTaking peopleA Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
- Where
- Boras, Gothenburg, Halmstad, Kalmar, Linkoping, Lulea, Lund, Orebro, Solna, Trollhattan, Umeå, Uppsala, Varberg
- Életkor
- 75 év and over
- People
- 300 worldwide
- Run by
- Nordic Lymphoma Group
See details and how to joinNCT04332822 · EU 2022-502887-19-00